Galectin-3 identified as key driver of chemoresistance in pancreatic cancer
Pancreatic cancer is often diagnosed in an advanced stage and is characterized by a poor disease diagnosis and increasing mortality. Gallactin -3 (GAL -3), a cimely protein, plays a versatile role in running the progress of Penocular Adenocarcinoma (PAAD). While its interaction with tumor micro-verse cells is well documented, the specific mechanisms by which the […]